ICD-10 CM Codes that support Medical Necessity for CPT Code 86003 Part 03

T41.45XS Adverse effect of unspecified anesthetic, sequela
T41.45XD Adverse effect of unspecified anesthetic, subsequent encounter
T43.205A Adverse effect of unspecified antidepressants, initial encounter
T43.205S Adverse effect of unspecified antidepressants, sequela
T43.205D Adverse effect of unspecified antidepressants, subsequent encounter
T42.75XA Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
T42.75XS Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
T42.75XD Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
T43.505A Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
T43.505S Adverse effect of unspecified antipsychotics and neuroleptics, sequela
T43.505D Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
T48.205A Adverse effect of unspecified drugs acting on muscles, initial encounter
T48.205S Adverse effect of unspecified drugs acting on muscles, sequela
T48.205D Adverse effect of unspecified drugs acting on muscles, subsequent encounter
T44.905A Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
T44.905S Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
T44.905D Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
T50.905A Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
T50.905S Adverse effect of unspecified drugs, medicaments and biological substances, sequela
T50.905D Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter
T45.605A Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.605S Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
T45.605D Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
T41.205A Adverse effect of unspecified general anesthetics, initial encounter
T41.205S Adverse effect of unspecified general anesthetics, sequela
T41.205D Adverse effect of unspecified general anesthetics, subsequent encounter
T38.905A Adverse effect of unspecified hormone antagonists, initial encounter
T38.905S Adverse effect of unspecified hormone antagonists, sequela
T38.905D Adverse effect of unspecified hormone antagonists, subsequent encounter
T38.805A Adverse effect of unspecified hormones and synthetic substitutes, initial encounter
T38.805S Adverse effect of unspecified hormones and synthetic substitutes, sequela
T38.805D Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
T40.605A Adverse effect of unspecified narcotics, initial encounter
T40.605S Adverse effect of unspecified narcotics, sequela
T40.605D Adverse effect of unspecified narcotics, subsequent encounter
T39.95XA Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
T39.95XS Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
T39.95XD Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
T45.95XA Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
T45.95XS Adverse effect of unspecified primarily systemic and hematological agent, sequela
T45.95XD Adverse effect of unspe
T40.905A Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
T40.905S Adverse effect of unspecified psychodysleptics [hallucinogens], sequela
T40.905D Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
T43.605A Adverse effect of unspecified psychostimulants, initial encounter
T43.605S Adverse effect of unspecified psychostimulants, sequela
T43.605D Adverse effect of unspecified psychostimulants, subsequent encounter
T43.95XA Adverse effect of unspecified psychotropic drug, initial encounter
T43.95XS Adverse effect of unspecified psychotropic drug, sequela
T43.95XD Adverse effect of unspecified psychotropic drug, subsequent encounter
T36.95XA Adverse effect of unspecified systemic antibiotic, initial encounter
T36.95XS Adverse effect of unspecified systemic antibiotic, sequela
T36.95XD Adverse effect of unspecified systemic antibiotic, subsequent encounter
T37.95XA Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
T37.95XS Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela
T37.95XD Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
T49.95XA Adverse effect of unspecified topical agent, initial encounter
T49.95XS Adverse effect of unspecified topical agent, sequela
T49.95XD Adverse effect of unspecified topical agent, subsequent encounter
T45.2X5A Adverse effect of vitamins, initial encounter
T45.2X5S Adverse effect of vitamins, sequela
T45.2X5D Adverse effect of vitamins, subsequent encounter
B44.81 Allergic bronchopulmonary aspergillosis
L23.9 Allergic contact dermatitis, unspecified cause
J30.81 Allergic rhinitis due to animal (cat) (dog) hair and dander
J30.5 Allergic rhinitis due to food
J30.1 Allergic rhinitis due to pollen
L50.0 Allergic urticaria
Z88.6 Allergy status to analgesic agent status
Z88.4 Allergy status to anesthetic agent status
Z88.5 Allergy status to narcotic agent status
Z88.1 Allergy status to other antibiotic agents status
Z88.3 Allergy status to other anti-infective agents status
Z88.8 Allergy status to other drugs, medicaments and biological substances status
Z88.0 Allergy status to penicillin
Z88.7 Allergy status to serum and vaccine status
Z88.2 Allergy status to sulfonamides status
Z91.012 Allergy to eggs
Z91.011 Allergy to milk products
Z91.018 Allergy to other foods
Z91.010 Allergy to peanuts
Z91.013 Allergy to seafood
T78.40XA Allergy, unspecified, initial encounter
T80.51XA Anaphylactic reaction due to administration of blood and blood products, initial encounter
T88.6XXA Anaphylactic reaction due to adverse effect of correct drug or medicament
properly administered, initial encounter
T78.08XA Anaphylactic reaction due to eggs, initial encounter
T78.06XA Anaphylactic reaction due to food additives, initial encounter
T78.04XA Anaphylactic reaction due to fruits and vegetables, initial encounter
T78.07XA Anaphylactic reaction due to milk and dairy products, initial encounter
T78.03XA Anaphylactic reaction due to other fish, initial encounter
T78.09XA Anaphylactic reaction due to other food products, initial encounter
T80.59XA Anaphylactic reaction due to other serum, initial encounter
T78.01XA Anaphylactic reaction due to peanuts, initial encounter
T78.02XA Anaphylactic reaction due to shellfish (crustaceans), initial encounter
T78.05XA Anaphylactic reaction due to tree nuts and seeds, initial encounter
T78.00XA Anaphylactic reaction due to unspecified food, initial encounter
T80.52XA Anaphylactic reaction due to vaccination, initial encounter
T78.2XXA Anaphylactic shock, unspecified, initial encounter
T78.3XXA Angioneurotic edema, initial encounter
R43.0 Anosmia
L20.81 Atopic neurodermatitis
L20.0 Besnier’s prurigo
J35.02 Chronic adenoiditis
H65.413 Chronic allergic otitis media, bilateral
H65.412 Chronic allergic otitis media, left ear
H65.411 Chronic allergic otitis media, right ear
J32.2 Chronic ethmoidal sinusitis
H68.023 Chronic Eustachian salpingitis, bilateral
H68.022 Chronic Eustachian salpingitis, left ear
H68.021 Chronic Eustachian salpingitis, right ear
J32.1 Chronic frontal sinusitis
H10.413 Chronic giant papillary conjunctivitis, bilateral
H10.412 Chronic giant papillary conjunctivitis, left eye
H10.411 Chronic giant papillary conjunctivitis, right eye
J32.0 Chronic maxillary sinusitis
J31.1 Chronic nasopharyngitis
J31.2 Chronic pharyngitis
J31.0 Chronic rhinitis
H65.23 Chronic serous otitis media, bilateral
H65.22 Chronic serous otitis media, left ear
H65.21 Chronic serous otitis media, right ear
J32.3 Chronic sphenoidal sinusitis
K29.30 Chronic superficial gastritis without bleeding
J35.01 Chronic tonsillitis
J35.03 Chronic tonsillitis and adenoiditis
L50.6 Contact urticaria
R05 Cough
J45.991 Cough variant asthma
L30.2 Cutaneous autosensitization
L27.2 Dermatitis due to ingested food
L27.8 Dermatitis due to other substances taken internally
L27.9 Dermatitis due to unspecified substance taken internally
L50.3 Dermatographic urticaria
L20.82 Flexural eczema
L27.0 Generalized skin eruption due to drugs and medicaments taken internally
J35.2 Hypertrophy of adenoids
J34.3 Hypertrophy of nasal turbinates
J35.1 Hypertrophy of tonsils
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids
L50.1 Idiopathic urticaria
L20.84 Intrinsic (allergic) eczema
L24.9 Irritant contact dermatitis, unspecified cause
L27.1 Localized skin eruption due to drugs and medicaments taken internally
J45.21 Mild intermittent asthma with (acute) exacerbation
J45.22 Mild intermittent asthma with status asthmaticus
J45.20 Mild intermittent asthma, uncomplicated
J45.31 Mild persistent asthma with (acute) exacerbation
J45.32 Mild persistent asthma with status asthmaticus
J45.30 Mild persistent asthma, uncomplicated
J45.41 Moderate persistent asthma with (acute) exacerbation
J45.42 Moderate persistent asthma with status asthmaticus
J45.40 Moderate persistent asthma, uncomplicated
R09.81 Nasal congestion
J34.81 Nasal mucositis (ulcerative)
L30.0 Nummular dermatitis
J01.81 Other acute recurrent sinusitis
J01.80 Other acute sinusitis
T78.1XXA Other adverse food reactions, not elsewhere classified, initial encounter
J30.89 Other allergic rhinitis
Z91.09 Other allergy status, other than to drugs and biological substances
T78.49XA Other allergy, initial encounter
J45.998 Other asthma
L20.89 Other atopic dermatitis
H10.45 Other chronic allergic conjunctivitis
H65.493 Other chronic nonsuppurative otitis media, bilateral
H65.492 Other chronic nonsuppurative otitis media, left ear
H65.491 Other chronic nonsuppurative otitis media, right ear
R43.8 Other disturbances of smell and taste
R06.09 Other forms of dyspnea
K29.60 Other gastritis without bleeding
Z91.048 Other nonmedicinal substance allergy status
J33.8 Other polyp of sinus
J30.2 Other seasonal allergic rhinitis
T80.61XA Other serum reaction due to administration of blood and blood products, initial encounter
T80.69XA Other serum reaction due to other serum, initial encounter
T80.62XA Other serum reaction due to vaccination, initial encounter
L30.8 Other specified dermatitis
J34.89 Other specified disorders of nose and nasal sinuses
L50.8 Other urticaria
H66.93 Otitis media, unspecified, bilateral
H66.92 Otitis media, unspecified, left ear
H66.91 Otitis media, unspecified, right ear
R43.2 Parageusia
R43.1 Parosmia
T39.1X1A Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter
T39.1X1S Poisoning by 4-Aminophenol derivatives, accidental (unintentional), sequela
T39.1X1D Poisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter
T39.1X3A Poisoning by 4-Aminophenol derivatives, assault, initial encounter
T39.1X3S Poisoning by 4-Aminophenol derivatives, assault, sequela
T39.1X3D Poisoning by 4-Aminophenol derivatives, assault, subsequent encounter
T39.1X2A Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter
T39.1X2S Poisoning by 4-Aminophenol derivatives, intentional self-harm, sequela
T39.1X2D Poisoning by 4-Aminophenol derivatives, intentional self-harm, subsequent encounter
T39.1X4A Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter
T39.1X4S Poisoning by 4-Aminophenol derivatives, undetermined, sequela
T39.1X4D Poisoning by 4-Aminophenol derivatives, undetermined, subsequent encounter
T44.6X1A Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter
T44.6X1S Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), sequela
T44.6X1D Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter
T44.6X3A Poisoning by alpha-adrenoreceptor antagonists, assault, initial encounter
T44.6X3S Poisoning by alpha-adrenoreceptor antagonists, assault, sequela
T44.6X3D Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter
T44.6X2A Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter
T44.6X2S Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, sequela
T44.6X2D Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter
T44.6X4A Poisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter
T44.6X4S Poisoning by alpha-adrenoreceptor antagonists, undetermined, sequela
T44.6X4D Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter
T36.5X1A Poisoning by aminoglycosides, accidental (unintentional), initial encounter
T36.5X1S Poisoning by aminoglycosides, accidental (unintentional), sequela
T36.5X1D Poisoning by aminoglycosides, accidental (unintentional), subsequent encounter
T36.5X3A Poisoning by aminoglycosides, assault, initial encounter
T36.5X3S Poisoning by aminoglycosides, assault, sequela
T36.5X3D Poisoning by aminoglycosides, assault, subsequent encounter
T36.5X2A Poisoning by aminoglycosides, intentional self-harm, initial encounter
T36.5X2S Poisoning by aminoglycosides, intentional self-harm, sequela
T36.5X2D Poisoning by aminoglycosides, intentional self-harm, subsequent encounter
T36.5X4A Poisoning by aminoglycosides, undetermined, initial encounter
T36.5X4S Poisoning by aminoglycosides, undetermined, sequela
T36.5X4D Poisoning by aminoglycosides, undetermined, subsequent encounter
T43.621A Poisoning by amphetamines, accidental (unintentional), initial encounter
T43.621S Poisoning by amphetamines, accidental (unintentional), sequela
T43.621D Poisoning by amphetamines, accidental (unintentional), subsequent encounter
T43.623A Poisoning by amphetamines, assault, initial encounter
T43.623S Poisoning by amphetamines, assault, sequela
T43.623D Poisoning by amphetamines, assault, subsequent encounter
T43.622A Poisoning by amphetamines, intentional self-harm, initial encounter
T43.622S Poisoning by amphetamines, intentional self-harm, sequela
T43.622D Poisoning by amphetamines, intentional self-harm, subsequent encounter
T43.624A Poisoning by amphetamines, undetermined, initial encounter
T43.624S Poisoning by amphetamines, undetermined, sequela
T43.624D Poisoning by amphetamines, undetermined, subsequent encounter
T50.7X1A Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), initial encounter
T50.7X1S Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), sequela
T50.7X1D Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), subsequent encounter
T50.7X3A Poisoning by analeptics and opioid receptor antagonists, assault, initial encounter
T50.7X3S Poisoning by analeptics and opioid receptor antagonists, assault, sequela
T50.7X3D Poisoning by analeptics and opioid receptor antagonists, assault, subsequent encounter
T50.7X2A Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, initial encounter
T50.7X2S Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, sequela
T50.7X2D Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, subsequent encounter
T50.7X4A Poisoning by analeptics and opioid receptor antagonists, undetermined, initial encounter
T50.7X4S Poisoning by analeptics and opioid receptor antagonists, undetermined, sequela
T50.7X4D Poisoning by analeptics and opioid receptor antagonists, undetermined, subsequent encounter
T38.7X1A Poisoning by androgens and anabolic congeners, accidental (unintentional), initial encounter
T38.7X1S Poisoning by androgens and anabolic congeners, accidental (unintentional), sequela
T38.7X1D Poisoning by androgens and anabolic congeners, accidental (unintentional), subsequent encounter
T38.7X3A Poisoning by androgens and anabolic congeners, assault, initial encounter
T38.7X3S Poisoning by androgens and anabolic congeners, assault, sequela
T38.7X3D Poisoning by androgens and anabolic congeners, assault, subsequent encounter
T38.7X2A Poisoning by androgens and anabolic congeners, intentional self-harm, initial encounter
T38.7X2S Poisoning by androgens and anabolic congeners, intentional self-harm, sequela
T38.7X2D Poisoning by androgens and anabolic congeners, intentional self-harm, subsequent encounter
T38.7X4A Poisoning by androgens and anabolic congeners, undetermined, initial encounter
T38.7X4S Poisoning by androgens and anabolic congeners, undetermined, sequela
T38.7X4D Poisoning by androgens and anabolic congeners, undetermined, subsequent encounter
T46.4X1A Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
T46.4X1S Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
T46.4X1D Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
T46.4X3A Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
T46.4X3S Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
T46.4X3D Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
T46.4X2A Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
T46.4X2S Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
T46.4X2D Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
T46.4X4A Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
T46.4X4S Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
T46.4X4D Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
T38.811A Poisoning by anterior pituitary [adenohypophyseal] hormones, accidental (unintentional), initial encounter
T38.811S Poisoning by anterior pituitary [adenohypophyseal] hormones, accidental (unintentional), sequela
T38.811D Poisoning by anterior pituitary [adenohypophyseal] hormones, accidental (unintentional), subsequent encounter
T38.813A Poisoning by anterior pituitary [adenohypophyseal] hormones, assault, initial encounter
T38.813S Poisoning by anterior pituitary [adenohypophyseal] hormones, assault, sequela
T38.813D Poisoning by anterior pituitary [adenohypophyseal] hormones, assault, subsequent encounter
T38.812A Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional selfharm, initial encounter
T38.812S Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional selfharm, sequela
T38.812D Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional selfharm, subsequent encounter
T38.814A Poisoning by anterior pituitary [adenohypophyseal] hormones, undetermined, initial encounter
T38.814S Poisoning by anterior pituitary [adenohypophyseal] hormones, undetermined, sequela
T38.814D Poisoning by anterior pituitary [adenohypophyseal] hormones, undetermined, subsequent encounter
T37.4X1A Poisoning by anthelminthics, accidental (unintentional), initial encounter
T37.4X1S Poisoning by anthelminthics, accidental (unintentional), sequela
T37.4X1D Poisoning by anthelminthics, accidental (unintentional), subsequent encounter
T37.4X3A Poisoning by anthelminthics, assault, initial encounter
T37.4X3S Poisoning by anthelminthics, assault, sequela
T37.4X3D Poisoning by anthelminthics, assault, subsequent encounter
T37.4X2A Poisoning by anthelminthics, intentional self-harm, initial encounter
T37.4X2S Poisoning by anthelminthics, intentional self-harm, sequela
T37.4X2D Poisoning by anthelminthics, intentional self-harm, subsequent encounter
T37.4X4A Poisoning by anthelminthics, undetermined, initial encounter
T37.4X4S Poisoning by anthelminthics, undetermined, sequela
T37.4X4D Poisoning by anthelminthics, undetermined, subsequent encounter
T45.0X1A Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
T45.0X1S Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), sequela
T45.0X1D Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter
T45.0X3A Poisoning by antiallergic and antiemetic drugs, assault, initial encounter
T45.0X3S Poisoning by antiallergic and antiemetic drugs, assault, sequela
T45.0X3D Poisoning by antiallergic and antiemetic drugs, assault, subsequent encounter
T45.0X2A Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
T45.0X2S Poisoning by antiallergic and antiemetic drugs, intentional self-harm, sequela
T45.0X2D Poisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter
T45.0X4A Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
T45.0X4S Poisoning by antiallergic and antiemetic drugs, undetermined, sequela
T45.0X4D Poisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter
T48.6X1A Poisoning by antiasthmatics, accidental (unintentional), initial encounter
T48.6X1S Poisoning by antiasthmatics, accidental (unintentional), sequela
T48.6X1D Poisoning by antiasthmatics, accidental (unintentional), subsequent encounter
T48.6X3A Poisoning by antiasthmatics, assault, initial encounter
T48.6X3S Poisoning by antiasthmatics, assault, sequela
T48.6X3D Poisoning by antiasthmatics, assault, subsequent encounter
T48.6X2A Poisoning by antiasthmatics, intentional self-harm, initial encounter
T48.6X2S Poisoning by antiasthmatics, intentional self-harm, sequela
T48.6X2D Poisoning by antiasthmatics, intentional self-harm, subsequent encounter
T48.6X4A Poisoning by antiasthmatics, undetermined, initial encounter
T48.6X4S Poisoning by antiasthmatics, undetermined, sequela
T48.6X4D Poisoning by antiasthmatics, undetermined, subsequent encounter
T44.0X1A Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter
T44.0X1S Poisoning by anticholinesterase agents, accidental (unintentional), sequela
T44.0X1D Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter
T44.0X3A Poisoning by anticholinesterase agents, assault, initial encounter
T44.0X3S Poisoning by anticholinesterase agents, assault, sequela
T44.0X3D Poisoning by anticholinesterase agents, assault, subsequent encounter
T44.0X2A Poisoning by anticholinesterase agents, intentional self-harm, initial encounter
T44.0X2S Poisoning by anticholinesterase agents, intentional self-harm, sequela
T44.0X2D Poisoning by anticholinesterase agents, intentional self-harm, subsequent
encounter
T44.0X4A Poisoning by anticholinesterase agents, undetermined, initial encounter
T44.0X4S Poisoning by anticholinesterase agents, undetermined, sequela
T44.0X4D Poisoning by anticholinesterase agents, undetermined, subsequent encounter
T45.7X1A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
T45.7X1S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela
T45.7X1D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter
T45.7X3A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
T45.7X3S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela
T45.7X3D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter
T45.7X2A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
T45.7X2S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela
T45.7X2D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter
T45.7X4A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
T45.7X4S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela
T45.7X4D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter
T45.511A Poisoning by anticoagulants, accidental (unintentional), initial encounter
T45.511S Poisoning by anticoagulants, accidental (unintentional), sequela
T45.511D Poisoning by anticoagulants, accidental (unintentional), subsequent encounter
T45.513A Poisoning by anticoagulants, assault, initial encounter
T45.513S Poisoning by anticoagulants, assault, sequela
T45.513D Poisoning by anticoagulants, assault, subsequent encounter
T45.512A Poisoning by anticoagulants, intentional self-harm, initial encounter
T45.512S Poisoning by anticoagulants, intentional self-harm, sequela
T45.512D Poisoning by anticoagulants, intentional self-harm, subsequent encounter
T45.514A Poisoning by anticoagulants, undetermined, initial encounter
T45.514S Poisoning by anticoagulants, undetermined, sequela
T45.514D Poisoning by anticoagulants, undetermined, subsequent encounter
T47.6X1A Poisoning by antidiarrheal drugs, accidental (unintentional), initial encounter
T47.6X1S Poisoning by antidiarrheal drugs, accidental (unintentional), sequela
T47.6X1D Poisoning by antidiarrheal drugs, accidental (unintentional), subsequent encounter
T47.6X3A Poisoning by antidiarrheal drugs, assault, initial encounter
T47.6X3S Poisoning by antidiarrheal drugs, assault, sequela
T47.6X3D Poisoning by antidiarrheal drugs, assault, subsequent encounter
T47.6X2A Poisoning by antidiarrheal drugs, intentional self-harm, initial encounter
T47.6X2S Poisoning by antidiarrheal drugs, intentional self-harm, sequela
T47.6X2D Poisoning by antidiarrheal drugs, intentional self-harm, subsequent encounter
T47.6X4A Poisoning by antidiarrheal drugs, undetermined, initial encounter